Stojkovski I, Kochova K, Slaveska Spirevska I, Janevik-Ivanovska E. SPIRONOLACTONE ORAL SUSPENSION (5 mg/mL): FORMULATION STRATEGIES AND PHYSICOCHEMICAL CHARACTERIZATION. kij [Internet]. 2026 Mar. 26 [cited 2026 Jun. 7];75(4):347-54. Available from: https://ojs.ikm.mk/index.php/kij/article/view/8202